Although core needle biopsies are often done to diagnose metastatic disease, our findings indicate that a single core needle might be insufficient to establish presence or absence of NY-ESO-1 in metastatic RCC, and whole tumor specimens or additional cores might be needed. This evidence concerns the gene CTAG1B and metastatic neoplasm.